查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1497544

生物标记测试服务市场：按服务、技术、疾病领域、应用、最终用户 - 2024-2030 年全球预测

Biomarker Testing Services Market by Services, Techonology, Disease Area, Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

生物标记检测服务市场规模预计2023年为9.649亿美元，2024年达到10.3196亿美元，预计2030年将达到15.8504亿美元，复合年增长率为7.34%。

生物标记检测服务是对人体内生物标记的临床评估和分析，这些生物标记表明正常或病理症状以及对治疗性介入的药理反应。生物标记在癌症、心血管疾病、神经系统疾病等多种疾病的早期检测、诊断和治疗效果监测中发挥重要作用。全球遗传和慢性疾病数量的增加、人们对生物标誌物在个人化医疗中的效用的日益认识以及生物技术的进步推动了对生物标誌物测试服务的需求。生物标记特异性测试和治疗方法的核准也得到支持性监管环境的支持。然而，与生物标记测试相关的高成本以及对先进基础设施和技术的需求是主要障碍。此外，缺乏普遍接受的生物标记测试和检验过程标准使生物标记测试在临床实践中的普及变得复杂，并且生物标誌物测试的技术限制引起了人们对该技术准确性的担忧。然而，为了提高生物标记测试的准确性和可靠性，主要企业正在探索生物资讯学、基因组学和蛋白​​质组学的进步。此外，整合 AL/ML 和资料分析技术以增强生物标记分析和解释，以及学术机构、医疗保健提供者和产业参与企业之间的合作以加速生物标记研究和应用，将进一步推动产业成长。

主要市场统计
基准年[2023] 9.649 亿美元
预测年份 [2024] 1,031,960,000 美元
预测年份 [2030] 15.8504亿美元
复合年增长率（%） 7.34%

区域洞察

以美国和加拿大为中心的美洲地区由于其先进的医疗基础设施、高昂的医疗成本以及对研究和创新的高度重视，成为生物标记检测服务的重要市场。由于个人化医疗的趋势以及旨在早期发现和管理疾病的政府积极努力，美国在生物标记检测的采用方面处于领先地位。该地区还支持多项与生物标记技术相关的专利，显示该地区致力于开发更准确和更具预测性的诊断工具。由于其高度发展的医疗部门以及由 Horizo​​​​n Europe 等欧盟卫生计画支持的广泛研究活动，欧盟国家正在经历越来越多的生物标记物的采用。最近的焦点是肿瘤学和神经系统疾病，其中许多倡议旨在将生物标记测试纳入临床实践，以实现个人化治疗方法。欧盟对生物标誌物开发和生物标记测试的严格规定创建了支持生物技术创新的标准化框架。由于对卫生基础设施的大量投资以及对预防性医疗保健日益增长的兴趣，中东是一个充满希望的地区。在亚太地区，中国、日本和印度等国家正在展示生物标记测试服务的创新。这些国家的需求是由不断增长的医疗保健支出、日益增强的个人化医疗意识以及蓬勃发展的生物製药行业所推动的。由于政府和私营部门对研发的投资，中国的分子诊断技术正在快速发展。日本以其技术创新而闻名，在老龄化社会中，旨在早期检测和治疗策略的先进生物标记测试的采用率很高。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在生物标记测试服务市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可对生物标记物测试服务市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该细分市场竞争力的宝贵见解，包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在生物标记测试服务市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行概述

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 癌症治疗的发展和对高性能生物标记的需求增加
      • 政府对生物标誌研究的措施和投资
      • 改善生物标誌物测试的财务支援的可用性
    • 抑制因素
      • 生物标记测试是一个缓慢且昂贵的过程
    • 机会
      • 使用人工智慧和机器学习的生物标记测试工具和设备的进步
      • 提供生物标记测试和分析服务的新兴CDMO
    • 任务
      • 由于样本收集和缺乏可靠性而造成测试障碍
  • 市场区隔分析
    • 技术：不断进步，提升聚合酵素链锁反应技术的通用性、速度和扩增能力
    • 最终用户：生物标记测试服务在製药和生物技术公司治疗性介入的新用途
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章生物标记测试服务市场：依服务分类

  • 介绍
  • 生物标记测定的开发和检验
  • 流式细胞技术

第七章生物标记测试服务市场：依技术分类

  • 介绍
  • 酵素免疫分析法
  • 质谱
  • 次世代定序
  • 聚合酵素链锁反应

第八章生物标记检测服务市场：依疾病领域

  • 介绍
  • 自体免疫疾病
  • 癌症
  • 心血管疾病
  • 神经系统疾病

第九章生物标记测试服务市场：依应用分类

  • 介绍
  • 药物作用机制
  • 动态
  • 预测性临床研究
  • 预后

第 10 章 生物标记测试服务市场：依最终用户分类

  • 介绍
  • 合约研究组织
  • 製药和生物技术公司
  • 研究机构

第十一章美洲生物标记检测服务市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太生物标记检测服务市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲/中东/非洲生物标记检测服务市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Mayo Clinic Laboratories 和 Progentec 合作为自体免疫疾病患者提供先进的生物标记检测服务
    • 新的前列腺癌生物标记测试登陆美国市场
    • Quanterix 推出 LucentAD 生物标记血液检测，帮助医生诊断阿兹海默症患者
  • 战略分析和建议

第15章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-B16853779DF0

[180 Pages Report] The Biomarker Testing Services Market size was estimated at USD 964.90 million in 2023 and expected to reach USD 1,031.96 million in 2024, at a CAGR 7.34% to reach USD 1,585.04 million by 2030.

Biomarker testing services refer to the clinical evaluation and analysis of biological markers (biomarkers) in the human body, which are indicative of normal or pathological symptoms or pharmacologic responses to a therapeutic treatment intervention. Biomarkers play a critical role in early detection, diagnosis, and monitoring the efficacy of treatments for various diseases, including cancer, cardiovascular disorders, and neurological conditions. The need for biomarker testing services is driven by the increasing incidences of genetic and chronic diseases worldwide, the growing recognition of the utility of biomarkers in personalized medicine, and advancements in biotechnology. A supportive regulatory environment has also facilitated the approval of biomarker-based tests and therapies. However, the high costs associated with biomarker tests and the requirement for sophisticated infrastructure and technology pose significant barriers. Additionally, the lack of universally accepted standards for biomarker testing and validation processes complicates their widespread adoption in clinical settings, and technical limitations of biomarker testing raise concerns about the accuracy of the technology. However, key players are exploring advances in bioinformatics, genomics, and proteomics to enhance the accuracy and reliability of biomarker tests. Additionally, the integration of AL/ML and data analytics technologies to enhance biomarker analysis and interpretation and collaborations between academic institutions, healthcare providers, and industry players to accelerate biomarker research and application can further expand the growth of the industry.

KEY MARKET STATISTICS
Base Year [2023] USD 964.90 million
Estimated Year [2024] USD 1,031.96 million
Forecast Year [2030] USD 1,585.04 million
CAGR (%) 7.34%

Regional Insights

The Americas, particularly the U.S. and Canada, represent a significant market for biomarker testing services, attributed to advanced healthcare infrastructure, high healthcare expenditure, and a strong focus on research and innovation. The U.S. leads in the adoption of biomarker tests, driven by personalized healthcare trends and proactive government initiatives aiming at early disease detection and management. The region also supports numerous patents related to biomarker technology, showcasing a strong emphasis on developing more precise and predictive diagnostic tools. EU countries are witnessing a growing adoption of biomarker testing services due to the highly developed healthcare sector and extensive research activities supported by the EU's health programs, such as Horizon Europe. The recent focus has been on oncology and neurological disorders, with numerous initiatives aimed at integrating biomarker testing into clinical practice to enable personalized treatment approaches. EU's stringent regulations pertaining to biomarker development and biomarker testing have created a standardized framework for supporting innovations in biotechnology. The Middle East shows promise due to substantial investments in healthcare infrastructure and an increasing focus on preventative care. In the APAC region, nations such as China, Japan, and India showcase innovation in biomarker testing services. The need in these countries is driven by increasing healthcare spending, rising awareness regarding personalized medicine, and the burgeoning biopharmaceutical sector. China is witnessing rapid advancements in molecular diagnostics, fueled by both government and private sector investments in research and development. Japan, renowned for its technological innovation, sees a high adoption rate of advanced biomarker tests among its aging population, aiming for early detection and treatment strategies.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Biomarker Testing Services Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing cancer drug development and need for high-performing biomarkers
      • Government initiatives and investments for biomarker research
      • Improved availability of financial coverage for biomarker testing
    • Market Restraints
      • Time-consuming and expensive process of biomarker testing
    • Market Opportunities
      • Advancements in biomarker testing tools & equipment with AI & ML
      • Emerging CDMOs offering biomarker testing and analysis services
    • Market Challenges
      • Barriers in testing due to lack of sample collection and authenticity
  • Market Segmentation Analysis
    • Technology: Ongoing advancements to improve the versatility, speed, and amplification capabilities of polymerase chain reaction technology
    • End-User: Emerging utilization of biomarker testing services by pharmaceutical & biotechnology companies for therapeutic interventions
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biomarker Testing Services Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biomarker Testing Services Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Mayo Clinic Laboratories and Progentec Collaborate To Bring Advanced Biomarker Testing Services To Patients With Autoimmune Diseases

In a strategic move poised to transform autoimmune disease management, Mayo Clinic Laboratories, has teamed up with Progentec Diagnostics, an innovator in digital health and biomarker technologies. This collaboration is set to deliver Progentec's novel suite of biomarker blood tests across the U.S. and selected international markets, enhancing the accessibility of advanced diagnostic solutions for both healthcare providers and patients battling autoimmune diseases. [Published On: 2023-11-14]

Novel Prostate Cancer Biomarker Test Launches on US Market

Quest Diagnostics, in collaboration with Envision Sciences, has launched an innovative prostate cancer biomarker test in the United States, a groundbreaking development aimed at enhancing the precision of prostate cancer biopsy grading. This strategic collaboration seeks to address a significant clinical need impacting millions of men in their cancer staging, diagnosis, and treatment journeys. [Published On: 2023-08-10]

Quanterix Launches LucentAD Biomarker Blood Test To Aid Physician Diagnosis of Alzheimer's Disease In Patients

Quanterix Corporation has launched its innovative LucentAD test, designed to facilitate the evaluation process for healthcare providers in diagnosing early signs of Alzheimer's disease (AD) in patients presenting cognitive symptoms. This cutting-edge test aims to streamline the process for clinicians when assessing the likelihood of amyloid pathology-an indicator of Alzheimer's disease. [Published On: 2023-07-14]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biomarker Testing Services Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biomarker Testing Services Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC by Danaher Corporation, Agilent Technologies, Inc., Avid Bioservices, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, BiomarkerBay B. V., Bristol Myers Squibb, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Icon PLC, Intertek Group PLC, IQVIA, JSR Life Sciences, LLC, KCAS Group, Laboratory Corporation of America Holdings, LGC Group, Merck KGaA, Myriad Genetics, Inc., NeoGenomics Laboratories, Parexel International Corporation, PerkinElmer Inc., Randox Laboratories, SGS S.A., Shuwen Biotech Co., Ltd., Syneos Health, Thermo Fisher Scientific, Inc., and WuXi Biologics Inc..

Market Segmentation & Coverage

This research report categorizes the Biomarker Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Biomarker Assay Development & Validation
    • Flow Cytometry
  • Techonology
    • Enzyme-Linked Immunosorbent Assay
    • Mass Spectrometry
    • Next-Generation Sequencing
    • Polymerase Chain Reaction
  • Disease Area
    • Autoimmune Diseases
    • Cancer
    • Cardiovascular Diseases
    • Neurological Disorders
  • Application
    • Drug Mechanism of Action
    • Pharmacodynamic
    • Predictive Clinical Studies
    • Prognostic
  • End-User
    • Contract Research Oraganizations
    • Pharmaceutical & biotechnology companies
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cancer drug development and need for high-performing biomarkers
      • 5.1.1.2. Government initiatives and investments for biomarker research
      • 5.1.1.3. Improved availability of financial coverage for biomarker testing
    • 5.1.2. Restraints
      • 5.1.2.1. Time-consuming and expensive process of biomarker testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in biomarker testing tools & equipment with AI & ML
      • 5.1.3.2. Emerging CDMOs offering biomarker testing and analysis services
    • 5.1.4. Challenges
      • 5.1.4.1. Barriers in testing due to lack of sample collection and authenticity
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Ongoing advancements to improve the versatility, speed, and amplification capabilities of polymerase chain reaction technology
    • 5.2.2. End-User: Emerging utilization of biomarker testing services by pharmaceutical & biotechnology companies for therapeutic interventions
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Biomarker Testing Services Market, by Services

  • 6.1. Introduction
  • 6.2. Biomarker Assay Development & Validation
  • 6.3. Flow Cytometry

7. Biomarker Testing Services Market, by Techonology

  • 7.1. Introduction
  • 7.2. Enzyme-Linked Immunosorbent Assay
  • 7.3. Mass Spectrometry
  • 7.4. Next-Generation Sequencing
  • 7.5. Polymerase Chain Reaction

8. Biomarker Testing Services Market, by Disease Area

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Cancer
  • 8.4. Cardiovascular Diseases
  • 8.5. Neurological Disorders

9. Biomarker Testing Services Market, by Application

  • 9.1. Introduction
  • 9.2. Drug Mechanism of Action
  • 9.3. Pharmacodynamic
  • 9.4. Predictive Clinical Studies
  • 9.5. Prognostic

10. Biomarker Testing Services Market, by End-User

  • 10.1. Introduction
  • 10.2. Contract Research Oraganizations
  • 10.3. Pharmaceutical & biotechnology companies
  • 10.4. Research Institutes

11. Americas Biomarker Testing Services Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Biomarker Testing Services Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Biomarker Testing Services Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Mayo Clinic Laboratories and Progentec Collaborate To Bring Advanced Biomarker Testing Services To Patients With Autoimmune Diseases
    • 14.3.2. Novel Prostate Cancer Biomarker Test Launches on US Market
    • 14.3.3. Quanterix Launches LucentAD Biomarker Blood Test To Aid Physician Diagnosis of Alzheimer's Disease In Patients
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BIOMARKER TESTING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. BIOMARKER TESTING SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIOMARKER TESTING SERVICES MARKET DYNAMICS
  • FIGURE 7. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. BIOMARKER TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. BIOMARKER TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOMARKER TESTING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY BIOMARKER ASSAY DEVELOPMENT & VALIDATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY BIOMARKER ASSAY DEVELOPMENT & VALIDATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DRUG MECHANISM OF ACTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DRUG MECHANISM OF ACTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACODYNAMIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACODYNAMIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PREDICTIVE CLINICAL STUDIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PREDICTIVE CLINICAL STUDIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PROGNOSTIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PROGNOSTIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORAGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORAGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY A